NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 55 filers reported holding NEUROCRINE BIOSCIENCES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,632,000 | -54.0% | 1,190,000 | -55.7% | 0.06% | -51.5% |
| Q2 2019 | $3,550,000 | -2.4% | 2,685,000 | 0.0% | 0.13% | +6.3% |
| Q1 2019 | $3,638,000 | +95.0% | 2,685,000 | +69.2% | 0.13% | +93.8% |
| Q4 2018 | $1,866,000 | -31.6% | 1,587,000 | 0.0% | 0.06% | -16.7% |
| Q3 2018 | $2,727,000 | -30.3% | 1,587,000 | -41.2% | 0.08% | -30.4% |
| Q2 2018 | $3,913,000 | – | 2,697,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| III Capital Management | 12,500,000 | $17,262,000 | 3.12% |
| CSS LLC/IL | 24,395,000 | $33,616,000 | 1.59% |
| Mint Tower Capital Management B.V. | 9,000,000 | $12,407,000 | 1.46% |
| Context Partners Fund, L.P. | 3,000,000 | $4,125,000 | 0.90% |
| Context Capital Management, LLC | 3,000,000 | $4,125,000 | 0.90% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,258,000 | $5,971,000 | 0.71% |
| SSI INVESTMENT MANAGEMENT LLC | 5,888,000 | $8,100,000 | 0.70% |
| Aequim Alternative Investments LP | 3,000,000 | $4,155,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,181,000 | $44,437,000 | 0.40% |
| TWO SIGMA SECURITIES, LLC | 13,000,000 | $17,875,000 | 0.36% |